Han, Y.; Wang, J.; Wu, Y.; Xu, H.; Wang, Y.; Xu, B.
Optimal Choice as First-Line Therapy for Patients with Triple-Negative Breast Cancer: A Bayesian Network Meta-Analysis. Curr. Oncol. 2022, 29, 9172-9180.
https://doi.org/10.3390/curroncol29120718
AMA Style
Han Y, Wang J, Wu Y, Xu H, Wang Y, Xu B.
Optimal Choice as First-Line Therapy for Patients with Triple-Negative Breast Cancer: A Bayesian Network Meta-Analysis. Current Oncology. 2022; 29(12):9172-9180.
https://doi.org/10.3390/curroncol29120718
Chicago/Turabian Style
Han, Yiqun, Jiayu Wang, Yun Wu, Hangcheng Xu, Yan Wang, and Binghe Xu.
2022. "Optimal Choice as First-Line Therapy for Patients with Triple-Negative Breast Cancer: A Bayesian Network Meta-Analysis" Current Oncology 29, no. 12: 9172-9180.
https://doi.org/10.3390/curroncol29120718
APA Style
Han, Y., Wang, J., Wu, Y., Xu, H., Wang, Y., & Xu, B.
(2022). Optimal Choice as First-Line Therapy for Patients with Triple-Negative Breast Cancer: A Bayesian Network Meta-Analysis. Current Oncology, 29(12), 9172-9180.
https://doi.org/10.3390/curroncol29120718